UNAIDS study shows that the impact on production and logistics caused by COVID-19 could have a significant effect on antiretroviral therapy supply worldwide, but steps taken now could lessen the damage done
Rural communities in low- and middle-income countries face specific challenges in accessing health care. And yet, these communities are often the most vulnerable and most in need. So how can we overcome these barriers to provide everyone with the health care they have a right to? How do we maximize the available healthcare resources to effectively address inequalities and ensure sustainable service delivery?
Rural communities comprise about 40% of the country’s population of 57.8 million but, historically, these areas are the last to be considered when it comes to health provision by national, provincial and local authorities.
Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats needs efficient pharmaceutical services and treatment with quality medicines.
The PrEP Costing Guidelines provide a framework for estimating the cost of providing pre-exposure prophylaxis (PrEP), which is the use of antiretroviral (ARV) drugs for preventing the acquisition of HIV infection.
With funding from PEPFAR, the Human Resources for Health in 2030 (HRH2030) has developed, piloted, and field-tested a tool to help health facility staff and district health management teams optimize their health workforce for the roll-out of “Test and Start” utilizing